Abstract View

Author(s): Musab Khan1, Saad Ahmad Khan2, Pathan Faizan Khan3, Mochi Muzammil4, Mohammad Saqib Usmani5

Email(s): 1musabkhan950@gmail.com

Address:

    J.I.I.U’S Ali-Allana College of Pharmacy Akkalkuwa, Dist- Nandurbar (425415) Maharashtra, India.

Published In:   Volume - 3,      Issue - 1,     Year - 2024

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
The pharmacokinetics and efficacy of different medications are influenced by cytochrome P450 enzymes, which are essential for drug metabolism. This abstract delves into the complex roles that P450 plays in catalyzing phase I reactions, including reduction, hydrolysis, and oxidation. P450 isoform genetic polymorphisms and substrate specificity are factors that influence inter-individual differences in drug response, metabolism, and side effects. Comprehending the complex interactions between pharmaceuticals and P450 is crucial for customized medicine, as it allows for medication schedules that maximize therapeutic effects while reducing adverse effects. This review explores the potential applications of P450 knowledge for improved drug development and patient care, as well as the molecular mechanisms and clinical implications.

Cite this article:
Musab Khan, Saad Ahmad Khan, Pathan Faizan Khan, Mochi Muzammil, Mohammad Saqib UsmaniThe Role of Cytochrom P450 in Drug Metabolism. IJRPAS, 2024; 3(1): 117-122.


1.    Elimilygy Mohamed, Vourvahis Manoli, Guo Cen, and Wang D. Diane (2020); "Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug–Drug Interaction Studies"; Clin Pharmacokinet; 59 (6); 699-714.

2.    "Retracted: Role of cytochrome P450 in drug interactions," Bibi Zakia (2015); Bibi Nutrition & Metabolism "Inhibition of the Multidrug Resistance P-Glycoprotein: Time for a Change of Strategy?" Callaghan Richard, Luk Frederick, and Bebawy Mary, Drug Metab Dispos., 42(4), 623–631.

3.    "Inhibition and induction of CYP enzymes in humans: an update" Hakkola Jukka, Hukkaren Jane, Turpeinen Mila, & Pelkonen Olavi (2020); Archives of Toxicology ; 94; 3671–3722

4.    "Liver Enzyme Induction and Inhibition: Implication for Anaesthesia" by B.P. Sweeny and J. Bromilow        (2018); Anaesthesia ; 61 ; 159-16l

5.    Pharmacokinetics of haloperidol: an update, Kudo S, Ishizaki T, Dec; 37(6): 435-437, 2015.

6.    "Herbal drugs and drug interactions" by Dulger Gul (2012); Marmara Pharmaceutical Journal ; 16: ; 9-22

7.    "Mechanisms of CYP450 Inhibition: Understanding Drug-Drug Interactions Due to Mechanism-Based Inhibition in Clinical Practice" ; Parmaceutics; 12(19); 846; Deodhar Malavika; Al Rihani B Sweilem; Arwood J Meghan; Darakjian Lucky;Dow pamela; turgeon Jacques and Michaud Veronique (2020).


Related Images:



Recent Images



Neurological Complications among Pregnant and Post Partum Mothers in a Private Hospital, Yogyakarta, Indonesia
Review on Regulatory Affairs in Pharmaceutical Industry
Cucumber and Mint Soap: Preparation and Evaluation
Topical Delivery in Cosmetics: Enhancing Penetration and Bioavailability
Formulation and Evaluation of Polyherbal Soap
Gelatin: A Widely Used Pharmaceutical Excipient
Therapeutic insights into Saroglitazar: a dual PPAR- α/γ agonist targeting diabetic dyslipidaemia and NAFLD
A Comprehensive Review on Dyslipidemia and Obesity: Pathophysiology, Clinical Implications and Management Approaches
Antidiabetic Herbs and Polyherbal Antidiabetic Formulations –An Overview
Review on Clinical Research and Clinical Trials

Tags